Beximco Pharmaceuticals Ltd (BXPHARMA):企業の財務・戦略的SWOT分析

◆英語タイトル:Beximco Pharmaceuticals Ltd (BXPHARMA) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH82270FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:バングラデシュ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥66,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥99,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Beximco Pharmaceuticals Ltd (Beximco Pharma) is a manufacturer and exporter of generic medicines and active pharmaceutical ingredients (APIs). The company offers products in the therapeutic areas of allergic disorders, analgesics and antipyretic, anti-infectives, cardiovascular, central nervous system, cough and cold, endocrine and diabetes, eye care, gastrointestinal, intravenous fluids, muscloskeletal, oncology, respiratory, skin care, vitamins and minerals supplement, and others. Beximco Pharma also provides specialized drug delivery systems such as metered dose inhalers, dry powder inhalers, prefilled syringes, lyophilized injectables, oral soluble film, sterile ophthalmics, nasal sprays, and intravenous infusion fluids. The company exports its products to regional markets of the Asia, Africa, the US, and Australia. Beximco Pharma is headquartered in Dhaka, Bangladesh.

Beximco Pharmaceuticals Ltd Key Recent Developments

Jan 28,2021: Beximco Pharmaceuticals: Half year results 2020-21
Jan 18,2021: Beximco Pharmaceuticals: Board Changes
Jan 11,2021: Beximco Pharmaceuticals: Confirmation of Board changes
Dec 02,2020: Beximco Pharmaceuticals announces board changes
Nov 16,2020: Beximco Pharmaceuticals: Results for first quarter ended 30 September 2020

This comprehensive SWOT profile of Beximco Pharmaceuticals Ltd provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Beximco Pharmaceuticals Ltd including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Beximco Pharmaceuticals Ltd – Key Information
Beximco Pharmaceuticals Ltd – Overview
Beximco Pharmaceuticals Ltd – Key Employees
Beximco Pharmaceuticals Ltd – Key Employee Biographies
Beximco Pharmaceuticals Ltd – Key Operational Heads
Beximco Pharmaceuticals Ltd – Major Products and Services
Beximco Pharmaceuticals Ltd – History
Beximco Pharmaceuticals Ltd – Company Statement
Beximco Pharmaceuticals Ltd – Locations And Subsidiaries
Beximco Pharmaceuticals Ltd
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Beximco Pharmaceuticals Ltd – Business Description
Beximco Pharmaceuticals Ltd – Corporate Strategy
Beximco Pharmaceuticals Ltd – SWOT Analysis
SWOT Analysis – Overview
Beximco Pharmaceuticals Ltd – Strengths
Beximco Pharmaceuticals Ltd – Weaknesses
Beximco Pharmaceuticals Ltd – Opportunities
Beximco Pharmaceuticals Ltd – Threats
Beximco Pharmaceuticals Ltd – Key Competitors

Section 3 – Company Financial Performance Charts

Beximco Pharmaceuticals Ltd – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Beximco Pharmaceuticals Ltd, Key Information
Beximco Pharmaceuticals Ltd, Key Ratios
Beximco Pharmaceuticals Ltd, Share Data
Beximco Pharmaceuticals Ltd, Major Products and Services
Beximco Pharmaceuticals Ltd, History
Beximco Pharmaceuticals Ltd, Key Employees
Beximco Pharmaceuticals Ltd, Key Employee Biographies
Beximco Pharmaceuticals Ltd, Key Operational Heads
Beximco Pharmaceuticals Ltd, Other Locations
Beximco Pharmaceuticals Ltd, Subsidiaries
Beximco Pharmaceuticals Ltd, Key Competitors
Beximco Pharmaceuticals Ltd, SWOT Analysis
Beximco Pharmaceuticals Ltd, Ratios based on current share price
Beximco Pharmaceuticals Ltd, Annual Ratios
Beximco Pharmaceuticals Ltd, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Beximco Pharmaceuticals Ltd (BXPHARMA):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Mah Sing Group Berhad:企業の戦略・SWOT・財務情報
    Mah Sing Group Berhad - Strategy, SWOT and Corporate Finance Report Summary Mah Sing Group Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Bill Peach Group Limited:企業の戦略・SWOT・財務情報
    Bill Peach Group Limited - Strategy, SWOT and Corporate Finance Report Summary Bill Peach Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Dewan Housing Finance Corporation Limited:企業のM&A・事業提携・投資動向
    Dewan Housing Finance Corporation Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Dewan Housing Finance Corporation Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detaile …
  • Vietnam Prosperity Joint-Stock Commercial Bank (VPB):企業の財務・戦略的SWOT分析
    Vietnam Prosperity Joint-Stock Commercial Bank (VPB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s k …
  • Ra Pharmaceuticals Inc (RARX):医療機器:M&Aディール及び事業提携情報
    Summary Ra Pharmaceuticals Inc (Ra Pharmaceuticals) is a clinical stage biopharmaceutical company that develops therapeutics for the treatment of diseases caused due to uncontrolled activation of the complement system. Ra Pharmaceuticals develops its pipeline products through its proprietary peptide …
  • Bank Pekao SA:戦略・SWOT・企業財務分析
    Bank Pekao SA - Strategy, SWOT and Corporate Finance Report Summary Bank Pekao SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Kenya Power and Lighting Co Ltd (KPLC):企業の財務・戦略的SWOT分析
    Kenya Power and Lighting Co Ltd (KPLC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Summit Therapeutics Plc (SUMM):製薬・医療:M&Aディール及び事業提携情報
    Summary Summit Therapeutics Plc (Summit), formerly Summit Corp Plc is a clinical-stage drug discovery and development company that offer therapies. The company conducts research and development on the treatment of rare diseases and infectious diseases including duchenne muscular dystrophy and the in …
  • GfK SE:企業のM&A・事業提携・投資動向
    GfK SE - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's GfK SE Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital rais …
  • Abreos Biosciences Inc-製薬・医療分野:企業M&A・提携分析
    Summary Abreos Biosciences Inc (Abreos Biosciences) is a biotechnology company that develops laboratory-based and point-of-care (POC) tests for precision dosing of biologic drugs. The company’s technology platform veritope, allow monitoring of monoclonal antibody drug levels in blood (novel or biosi …
  • Meridian Energy Limited:企業の戦略・SWOT・財務情報
    Meridian Energy Limited - Strategy, SWOT and Corporate Finance Report Summary Meridian Energy Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Johnson & Johnson:企業の戦略・SWOT・財務情報
    Johnson & Johnson - Strategy, SWOT and Corporate Finance Report Summary Johnson & Johnson - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • The Chemours Company LLC:企業の戦略・SWOT・財務情報
    The Chemours Company LLC - Strategy, SWOT and Corporate Finance Report Summary The Chemours Company LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Majestic Wine plc (WINE):企業の財務・戦略的SWOT分析
    Majestic Wine plc (WINE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Vulcan Materials Company:企業の戦略・SWOT・財務分析
    Vulcan Materials Company - Strategy, SWOT and Corporate Finance Report Summary Vulcan Materials Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Paramount Resources Ltd (POU):企業の財務・戦略的SWOT分析
    Summary Paramount Resources Ltd (Paramount Resources) is an energy company that offers exploration, production, development, and marketing of oil and gas products. The company offers products such s crude oil, fuel oil, natural gas and natural gas liquids. It operates in three segments such as princ …
  • Yissum Research Development Company of the Hebrew University of Jerusalem Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Yissum Research Development Company of the Hebrew University of Jerusalem Ltd (YRDC) is a technology transfer company that offers marketing the inventions and know-how generated by the University's researchers and students. The company’s products include exelon, doxil, cherry tomatoes and lo …
  • DeNA Co Ltd (2432):企業の財務・戦略的SWOT分析
    DeNA Co Ltd (2432) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • OraMetrix Inc:医療機器:M&Aディール及び事業提携情報
    Summary OraMetrix Inc (OraMetrix), a subsidiary of Dentsply Sirona Inc is a provider of 3-D technology solutions for orthodontic care. The company offers offers suresmile, a software that helps doctors to visualize their treatment plan in the patient’s facial profile; fusion, which enables doctors t …
  • Flint Hills Resources LLC:企業の戦略的SWOT分析
    Flint Hills Resources LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆